Blog
RSS FeedPosted by Michael Wonder on 31 Dec 2021
New Zealand Pharmaceutical Schedule - 1 January 2022
1 January 2022 - The January 2022 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 11 Feb 2020
Paying tax on unfunded cancer medication outrageous, says Nelson patient
7 February 2020 - A Nelson man with a rare cancer is concerned the Government is taking millions of dollars ...
Posted by Michael Wonder on 13 Jun 2019
Pharmaceutical policy reforms to regulate drug prices in the Asia Pacific Region: the case of Australia, China, India, Malaysia, New Zealand, and South Korea
13 June 2019 - Medicine price directly affects affordability and access to medicines particularly in countries where a major portion of ...
Posted by Michael Wonder on 06 Feb 2019
Comparing PHARMAC's outcomes with those of Australia
7 February 2019 - New Zealand's Prime Minister Jacinda Ahern's claim that is unfair to compare PHARMAC's outcomes with those ...
Posted by Michael Wonder on 11 Sep 2017
Iron infusions in the community
11 September 2017 - Eligible people will now be able to receive ferric carboxymaltose iron infusions in some general practitioners’ ...
Posted by Michael Wonder on 02 Feb 2017
Mind the gap - an analysis of cancer medicines in New Zealand and Australia
2 February 2017 - When it comes making a difference in people’s lives, it’s not about how many medicines you ...
Posted by Michael Wonder on 18 Aug 2016
Subsidised access to new melanoma drugs: in need of further innovation?
19 August 2016 - New Zealand is now the melanoma capital of the world but is behind the rest of ...
Posted by Michael Wonder on 04 Nov 2015
Pharmac hits back at claims Australia has better access to high-cost cancer drugs
3 November 2015 - Pharmac has rebuffed claims New Zealanders have less access to cutting-edge cancer treatments, commissioning research they say ...
Posted by Michael Wonder on 03 Nov 2015
NZers getting access to best cancer medicines says PHARMAC
3 November 2015 - A new analysis of cancer medicine access in Australia and New Zealand shows that New Zealanders are ...